-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NvY0nVyRgtMdF4UuxvoYsR5z9mU+cjRizR2nLeRxhzomtUE2/bJhEeTZee5693bJ kInj+dd2dfL4yRZuIvyOoQ== 0000947871-10-001036.txt : 20101104 0000947871-10-001036.hdr.sgml : 20101104 20101104154154 ACCESSION NUMBER: 0000947871-10-001036 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20101104 FILED AS OF DATE: 20101104 DATE AS OF CHANGE: 20101104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SUN PHARMA GLOBAL INC CENTRAL INDEX KEY: 0001197088 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-22286 FILM NUMBER: 101164787 BUSINESS ADDRESS: STREET 1: SPARC AKOTA ROAD CITY: VADODARA STATE: A1 ZIP: 00000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SUN PHARMACEUTICAL INDUSTRIES LTD CENTRAL INDEX KEY: 0001197089 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-22286 FILM NUMBER: 101164788 BUSINESS ADDRESS: STREET 1: SPARC AKOTA ROAD CITY: VADODARA STATE: K7 ZIP: 390020 BUSINESS PHONE: 01191228212128 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TARO PHARMACEUTICAL INDUSTRIES LTD CENTRAL INDEX KEY: 0000906338 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 14 HAKTOR ST CITY: HAIFA BAY STATE: L3 ZIP: 26110 BUSINESS PHONE: 9143459001 MAIL ADDRESS: STREET 1: THREE SKYLINE DR CITY: HAWTHORNE STATE: NY ZIP: 10532 FORMER COMPANY: FORMER CONFORMED NAME: TARO VIT INDUSTRIES LTD /ISRAEL/ DATE OF NAME CHANGE: 19930601 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Alkaloida Chemical CO Exclusive Group Ltd. CENTRAL INDEX KEY: 0001438382 STATE OF INCORPORATION: K5 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-22286 FILM NUMBER: 101164786 BUSINESS ADDRESS: STREET 1: KABAY JANOS UT 29. CITY: TISZAVASVARI STATE: K5 ZIP: 4440 BUSINESS PHONE: 36.42.521.005 MAIL ADDRESS: STREET 1: KABAY JANOS UT 29. CITY: TISZAVASVARI STATE: K5 ZIP: 4440 4/A 1 ss104423_4a.xml X0303 4/A 2010-11-04 2010-09-29 0 0000906338 TARO PHARMACEUTICAL INDUSTRIES LTD TAROF 0001197089 SUN PHARMACEUTICAL INDUSTRIES LTD 17/B, MAHAL INDUSTRIAL ESTATE MAHAKALI CAVES ROAD, ANDHERI (EAST) MUMBAI, K7 400 093 INDIA 0 0 1 1 Affiliated Party 0001197088 SUN PHARMA GLOBAL INC INTERNATIONAL TRUST BUILDING P.O. BOX 659, ROAD TOWN TORTOLA, D8 00000 VIRGIN ISLANDS, BRITISH 0 0 1 1 Affiliated Party 0001438382 Alkaloida Chemical CO Exclusive Group Ltd. KABAY JANOS UT. 29. TISZAVASVARI, K5 4440 HUNGARY 0 0 1 1 Affiliated Party Ordinary Shares 2010-11-04 4 P 0 5159765 16.00 A 14497933 I See Footnote Equivalent to Common Stock. All Ordinary Shares of Taro Pharmaceutical Industries Ltd. (the "Issuer") control in the aggregate two-thirds of the voting power of the Issuer. This amount represents 58,000 Ordinary Shares acquired by Sun Pharma Global, Inc. ("Sun Pharma"), a direct wholly-owned subsidiary of Sun Pharmaceutical Industries Ltd. ("Sun"), on July 7, 2007 and 500 Ordinary Shares acquired by Sun Pharma on July 23, 2007, in each case in open market transactions; 3,712,557 Ordinary Shares acquired by Alkaloida Chemical Company Exclusive Group Ltd. ("Alkaloida"), an indirect subsidiary of Sun, on February 19, 2008 and 797,870 Ordinary Shares acquired by Alkaloida on June 23, 2008, in each case in a private transaction; 29,382 Ordinary Shares acquired by Alkaloida on September 14, 2010 upon the expiration of its tender offer to acquire all of Issuer's outstanding Ordinary Shares; and 2,405,937 Ordinary Shares acquired by Alkaloida pursuant to a letter agreement dated September 20, 2010. This amount also includes 2,333,922 Ordinary Shares indirectly acquired by Sun Pharmaceutical Industries Inc. ("Sun Michigan"), a Michigan corporation and a direct subsidiary of Sun, through a merger of a subsidiary of Sun Michigan with and into The Taro Development Corporation on October 1, 2010; and 5,159,765 Ordinary Shares acquired by Alkaloida on November 4, 2010 from Templeton Asset Management Ltd in a private transaction. In addition, Sun indirectly owns 13,575,000 Ordinary Shares which are restricted stock consisting of: (i) 3,770,833 Ordinary Shares acquired by Alkaloida on May 21, 2007 and 3,016,667 Ordinary Shares acquired by Alkaloida on May 30, 2007, in each case pursuant to the share purchase agreement dated May 18, 2007, between Alkaloida and the Issuer; (ii) 3,000,000 Ordinary Shares acquired by Alkaloida on August 2, 2007, pursuant to Sun's rights under the warrant, dated May 18, 2007, issued by the Issuer to Sun, and (iii) 3,712,500 Ordinary Shares acquired by Alkaloida on September 24, 2010 and 75,000 Ordinary Shares acquired by Alkaloida on September 27, 2010, in each case pursuant to a warrant dated August 2, 2007, between Sun and the Issuer. /s/ Sailesh T. Desai, Director of Sun Pharmaceutical Industries Ltd. 2010-11-04 /s/ Harin Mehta, Managing Director of Sun Pharma Global, Inc. 2010-11-04 /s/ Harin Mehta, Managing Director of Alkaloida Chemical Company Exclusive Group Ltd. 2010-11-04 EX-99.1 2 ss104423_ex9901.htm JOINT FILER INFORMATION

Exhibit 99.1

Form 4 Joint Filer Information

Name: Sun Pharma Global Inc.

Address: Registered Office:

International Trust Building

P.O. Box 659

Road Town, Tortola, British Virgin Islands

Office at Woodstock Asia Pascific DMCC,

Office No. 406

The Business Centre, Opp. Burjuman Centre,

Mashreq Bank Bldg.

Bank Street, P.O. Box 12850, Dubai, U.A.E.

Designated Filer: Sun Pharmaceutical Industries Ltd.

Issuer and Ticker Symbol: Taro Pharmaceutical Industries Ltd. (“TAROF”)

Date of Event Requiring Statement: 11/04/2010

Signature: By:	/s/ Harin Mehta
	Harin Mehta, Managing Director of
	Sun Pharma Global, Inc.

Name: Alkaloida Chemical Company Exclusive Group Ltd.

Address: Kabay János u. 29, H-4440 Tiszavasari,

The Republic of Hungary

Designated Filer: Sun Pharmaceutical Industries Ltd.

Issuer and Ticker Symbol: Taro Pharmaceutical Industries Ltd. (“TAROF”)

Date of Event Requiring Statement: 11/04/2010

Signature: By:	/s/ Harin Mehta
	Harin Mehta, Director of
	Alkaloida Chemical Company Exclusive Group Ltd.

-----END PRIVACY-ENHANCED MESSAGE-----